Baculoviral IAP repeat-containing protein

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(Redirecting to Ubiquitin protein ligase)
Current revision (10:17, 1 April 2019) (edit) (undo)
 
(24 intermediate revisions not shown.)
Line 1: Line 1:
-
#REDIRECT [[Ubiquitin protein ligase]]
+
<StructureSection load='' size='350' side='right' caption='Human Baculoviral IAP repeat-containing protein 2 BIR3 domain (magenta) complex with caspase-9 peptide (green) and Zn+2 ion (PDB code [[3d9t]]) ' scene='59/591978/Cv/1'>
 +
== Function ==
 +
 
 +
'''IAP'''s were discovered in baculoviruses and were shown to be involved in suppressing the host cell response to viral infection. <ref>PMID:9990849</ref><br />
 +
 
 +
*'''Baculoviral IAP repeat-containing protein 1''' (BIRC1 or NAIP) inhibits the activities of caspase-3,7,9. BIRC1 acts as mediator of neuronal survival in pathological conditions and prevents motor-neuron apoptosis.<br />
 +
*'''Baculoviral IAP repeat-containing protein 2''' (cIAP1) and '''Baculoviral IAP repeat-containing protein 3''' (cIAP2) inhibit apoptosis by interfering with the activation of caspase and by binding to TNFR-associated factors TRAF1 and TRAF2. cIAP1 is a multi-functional protein which acts as an E3 ubiquitin-protein ligase and plays a role in the modulation of the cell cycle. cIAP1 is involved in controlling b-cell survival under ER stress caused by lipotoxicity. Both cIAP1 and cIAP2 regulate NF-kB activation. cIAP2 inhibits apoptosis caused by serum deprivation but not by inducers of free radicals. <br />
 +
*For '''Baculoviral IAP repeat-containing protein 4''' see XIAP in [[Ubiquitin protein ligase]].<br />
 +
*For '''Baculoviral IAP repeat-containing protein 5''' see [[Survivin]].<br />
 +
*'''Baculoviral IAP repeat-containing protein 6''' (BIRC6) inhibits caspase-3,7,9. Has a role in the final stages of cytokinesis, vescilcle targeting to the site of abscission and ubiquitin conjugation.<br />
 +
*'''Baculoviral IAP repeat-containing protein 7''' or melanoma inhibitor of apoptosis (ML-IAP) contains one BIR and one RING domain. ML-IAP has 2 isoforms. Isoform-a protects cells from staurosporine-induced apoptosis and isoform-b protects cells from etoposide-induced apoptpsis.<br />
 +
*'''Baculoviral IAP repeat-containing protein 8''' (BIRC8).<br />
 +
== Disease ==
 +
 
 +
cIAP1 is a target for intervention against type 2 diabetes. Mutated or deleted BIRC1 were found in individuals with severe muscular atrophy.
 +
 
 +
== Relevance ==
 +
 
 +
IAP proteins suppress cell death by inhibiting the activity of caspases. As they are involved in apoptosis regulation, IAPs are of interest in cancer and autoimmune diseases therapy.
 +
 
 +
== Structural highlights ==
 +
 
 +
cIAPs domains include 3 BIR (zinc-finger found in apoptosis inhibitors) domains in the N-terminal, a UBA (Ubiquitin-Associated), CARD (Caspase Recruitment) and RING finger (zinc finger which contains Cys3-His-Cys4 motif) domain in the C-terminal.
 +
 
 +
<scene name='59/591978/Cv/3'>Zinc coordination site</scene> in human Baculoviral IAP repeat-containing protein 2 BIR3 domain (PDB code [[3d9t]])<ref>PMID:15657060</ref>
 +
 
 +
== 3D Structures of Baculoviral IAP repeat-containing protein ==
 +
[[Baculoviral IAP repeat-containing protein 3D structures]]
 +
 
 +
</StructureSection>
 +
 +
== References ==
 +
<references/>
 +
[[Category:Topic Page]]

Current revision

Human Baculoviral IAP repeat-containing protein 2 BIR3 domain (magenta) complex with caspase-9 peptide (green) and Zn+2 ion (PDB code 3d9t)

Drag the structure with the mouse to rotate

References

  1. Deveraux QL, Reed JC. IAP family proteins--suppressors of apoptosis. Genes Dev. 1999 Feb 1;13(3):239-52. PMID:9990849
  2. Raina D, Pandey P, Ahmad R, Bharti A, Ren J, Kharbanda S, Weichselbaum R, Kufe D. c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J Biol Chem. 2005 Mar 25;280(12):11147-51. Epub 2005 Jan 18. PMID:15657060 doi:10.1074/jbc.M413787200

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools